glp-1 options for type 2 diabetes and obesity 2025 New Guidelines in GLP-1s in 2025: Who's Using

Semaglutide belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists

Upon embarking on your weight loss journey, your doctor will start by 1 : You are generally considered a candidate for GLP-1 therapy if you have a: Body mass index (BMI) of 30kg/m 2 or higher 2 BMI of 27kg/m 2 or higher in the presence of high blood pressure, high cholesterol, type 2 diabetes, sleep apnea, or heart disease 2 Your doctor may prescribe GLP-1 medications at an even lower BMI if you are at a high risk of obesity-related health problems 3

Every patients experience with weight loss is unique, and so are their facial rejuvenation needs

1 Preventive Strategies Slower weight loss rates may help mitigate gallstone formation

Multiple clinical trials in photoaged skin (sun damage) have shown that topical GHK-Cu formulations improve skin appearance including reductions in fine lines and wrinkles, improvement in skin firmness and elasticity, enhancement of skin texture and smoothness, increase in skin thickness (reversing age-related dermal atrophy), improvement in skin clarity and reduction in hyperpigmentation, and overall rejuvenated appearance